COVID-19 for health professionals: Training, webinars and webcasts

On this page

Training for contact tracing

Register for our free training courses on contact tracing. You will need to make an account before being able to register. Our series of courses supplement local training and onboarding. They are not a requirement to conducting work in your jurisdiction. Health professionals must follow local/regional policies and procedures for contract tracing.

Webinars and webcasts on COVID-19 vaccines

2022

Overview of the Novavax Nuvaxovid and Medicago Covifenz COVID-19 vaccines (2022-05-10)

The purpose of the webcast is to:

  • discuss the clinical evidence for the Novavax Nuvaxovid and Medicago Covifenz COVID-19 vaccines
  • summarize NACI's recommendations for the use of Novavax Nuvaxovid and Medicago Covifenz COVID-19 vaccines

Needle fear, pain and vaccines: Introduction to the CARD system as a framework for vaccination delivery (2022-04-20)

The purpose of the webcast is to:

  • learn about contributors to stress-related reactions during vaccination and evidence-based strategies to improve the vaccine experience for people receiving vaccines and those who support them
  • introduce the CARD (comfort, ask, relax, distract) system as a framework for vaccination delivery

Building COVID-19 vaccine confidence before, during and after pregnancy (2022-03-17)

The purpose of the webinar is to:

  • discuss the challenges to vaccine confidence for individuals and families who are pregnant, considering pregnancy or lactating
  • identify strategies for building vaccine confidence among pregnant families, new parents, and those who intend to become pregnant

COVID-19 and vaccines during pregnancy and lactation: A summary of the evidence (2022-03-10)

The purpose of the webcast is to:

  • identify the risks associated with infection with SARS CoV-2 during pregnancy
  • explain the safety and effectiveness of mRNA vaccines in pregnancy and lactation, and for those intending to become pregnant
 

2021

COVID-19 vaccine for pediatric use in Canada (2021-12-13)

The purpose of the webinar is to:

  • identify the factors that parents or guardians should consider when deciding on COVID-19 vaccination for children aged 5 to 11 years
  • describe the COVID-19 pandemic among children 5 to 11 years of age in Canada
  • summarize the clinical trial information available on the COVID-19 vaccine authorized in children 5 to 11 years of age
  • explain NACI recommendations for children 5 to 11 years of age

Updated NACI recommendations on additional COVID-19 vaccine doses for the immunocompromised (2021-11-29)

The purpose of the webcast is to identify who should receive an additional dose on the basis of immune compromise as recommended by NACI.

For current recommendations, refer to COVID-19 vaccine: Canadian Immunization Guide.

Preparing for pediatric COVID-19 immunization and adult booster doses (2021-11-17)

The purpose of the webinar is to:

  • provide an overview of the Pfizer-BioNTech Comirnaty vaccine for children 5 to 11 years of age and its use and administration, as well as timing of the concurrent vaccination programs in fall and winter
  • share evidence and information on the management of vaccination pain and fear in children
  • provide models for the operations of immunization clinics and considerations for their use

Revaccination with COVID-19 vaccines after anaphylaxis (2021-11-17)

The purpose of this webinar is to:

  • explain the October 22, 2021, guidance from NACI regarding re-immunization of people with previous severe immediate allergic reactions (anaphylaxis) to COVID-19 vaccines or to their components or container
  • examine the evidence and rationale behind the recommendations
  • locate resources to facilitate safe immunization or reimmunization of people with severe immediate allergic reactions (anaphylaxis) following COVID-19 vaccines or to their components

Contraindications to COVID-19 vaccines (2021-11-09)

The purpose of the webcast is to identify contraindications and precautions to authorized COVID-19 vaccines as defined by NACI.

COVID-19 variants and vaccines (2021-06-23)

The purpose of the webinar is to:

  • explain the national surveillance systems that detect and track SARS-CoV2 variants, including variants of concern (VOCs), in Canada
  • discuss key findings on vaccine efficacy and effectiveness against VOCs, internationally and in Canada
  • summarize how predictive epidemiological models can inform Canadian forecasts and response to SARS-CoV2

Recommendations from NACI on COVID-19 vaccine interchangeability (2021-06-21)

The purpose of the webinar is to:

  • provide an overview of NACI and its role in COVID-19 vaccine planning
  • provide evidence for interchangeability of COVID-19 vaccines, including preclinical evidence, safety assessments and immunogenicity data
  • outline the NACI recommendations for interchangeability of authorized COVID-19 vaccines

For current recommendations, refer to COVID-19 vaccine: Canadian Immunization Guide.

Addressing COVID-19 vaccine hesitancy in clinical practice (2021-05-19)

The purpose of the webinar is to:

  • discuss COVID-19 vaccine hesitancy and describe evidence-based practices for promoting vaccine confidence and uptake
  • provide strategies for communicating about vaccines, including benefits and risks
  • discuss mis/disinformation related to vaccines and COVID-19, and describe barriers to vaccination

Recommendations from NACI on extended dose intervals for COVID-19 vaccines (2021-05-05)

The purpose of the webinar is to:

  • describe the efficacy and effectiveness of COVID-19 vaccines in the context of 1 or 2 doses
  • discuss the impacts of extended dose intervals of COVID-19 vaccines
  • present the NACI recommendations on extended dose intervals

For current recommendations, refer to COVID-19 vaccine: Canadian Immunization Guide.

Vaccine-induced immune thrombotic thrombocytopenia [VITT] (2021-04-21)

The purpose of the webinar is to:

  • provide an overview of VITT
  • explain clinical guidance for treatment of VITT
  • describe how to report VITT

Delayed injection site reactions and mRNA vaccines (2021-03-11)

The purpose of the webinar is to:

  • provide the features and management of delayed injection site reactions following administration of COVID-19 vaccines
  • describe an overview of the Canadian Adverse Events Following Immunization Surveillance System and data on the Moderna Spikevax and Pfizer-BioNTech Comirnaty vaccines
  • provide guidance on distinguishing these delayed injection reactions from other local reactions, such as cellulitis

Planning for COVID-19 vaccines and immunization clinics (2021-03-01)

The purpose of the webinar is to:

  • review the approach to planning for immunization clinics, including key planning parameters, required supplies, staffing, training and site selection
  • provide information on infection prevention and control strategies and preparation for medical emergencies
  • outline the importance of communication, collaboration and ongoing feedback to support running successful immunization clinics

COVID-19 vaccine foundations for allied, new and returning health care providers (2021-02-25)

The purpose of the webinar is to:

  • describe Health Canada’s COVID-19 vaccine regulatory authorization process
  • explain the role of NACI in COVID-19 vaccine guidance development
  • provide a description of COVID-19 vaccines that may be available in Canada

Allergies and low dead volume syringes (2021-02-10)

The purpose of the webinar is to:

  • provide an outline of Canada’s vaccine safety system
  • describe allergy-related contraindication or precautions to COVID-19 vaccination
  • describe the features and management of anaphylaxis and other acute events following administration of COVID-19 vaccines

The discussion on low dead volume syringes describes:

  • what low dead volume means
  • methods to support withdrawing 6 doses per vial
  • the process to assess the dead volume of a syringe

2020

Recommendations from NACI on the use of the Moderna Spikevax COVID-19 vaccine (2020-12-30)

The purpose of the webinar is to:

  • explain the characteristics of the Moderna Spikevax COVID-19 vaccine platform
  • provide clinical evidence for the Moderna Spikevax COVID-19 vaccine
  • discuss the handling and administering the Moderna Spikevax COVID-19 vaccine

For current recommendations, refer to COVID-19 vaccine: Canadian Immunization Guide.

Recommendations from NACI on the use of the Pfizer-BioNTech Comirnaty COVID-19 vaccine (2020-12-18)

The purpose of the webinar is to:

  • describe the characteristics of the Pfizer-BioNTech Comirnaty COVID-19 vaccine
  • discuss key information on handling and administering the Pfizer-BioNTech Comirnaty COVID-19 vaccine
  • explain the clinical evidence for the Pfizer-BioNTech Comirnaty COVID-19 vaccine
  • summarize NACI recommendations on the use of the Pfizer-BioNTech Comirnaty COVID-19 vaccine

For current recommendations, refer to COVID-19 vaccine: Canadian Immunization Guide.

COVID-19 vaccine foundations for health care providers (2020-12-14)

Module 1:

The presentation:

  • describes the Health Canada vaccine approval pathway for vaccines, including changes under the interim order and the status of current rolling submissions
  • underscores the guidance delivered and expected from NACI

Module 2:

The presentation:

  • describes the platform technologies used by candidate vaccines against SARS-COV-2
  • discusses mRNA vaccines in development by Pfizer-BioNTech Comirnaty and Moderna Spikevax

Module 3:

The presentation:

  • describes the infection prevention and control requirements for safely providing COVID-19 vaccines given the ongoing circulation of SARS-CoV-2
  • highlights key messages regarding vaccine storage and handling requirements
  • provides planning parameters and strategies for organizing mass immunization clinics

For more information on the webinars, consult the following:

Webinars on influenza vaccination in the context of COVID-19

Seasonal influenza immunization for 2021 and 2022 (2021-10-27)

The purpose of the webinar is to:

  • discuss the importance of seasonal influenza vaccination and COVID-19 vaccination during the COVID-19 pandemic
  • identify and address barriers to seasonal influenza vaccine uptake
  • apply NACI recommendations on seasonal influenza vaccine use for the 2021 and 2022 season
  • identify where to access NACI and relevant Public Health Agency of Canada resources relevant to vaccination during the 2021 and 2022 season

For more information on the webinars, consult the following:

Related links

Report a problem or mistake on this page
Please select all that apply:

Thank you for your help!

You will not receive a reply. For enquiries, contact us.

Date modified: